# Rapid HIV Treatment Initiation, Access and Engagement in Care

> **NCT03512964** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 32 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Dolutegravir 50 MG
- **DRUG:** Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet [DESCOVY]

## Key facts

- **NCT ID:** NCT03512964
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-29
- **Primary completion:** 2020-09-13
- **Final completion:** 2020-09-13
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03512964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03512964, "Rapid HIV Treatment Initiation, Access and Engagement in Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03512964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*